Glycemic control indicators in patients with neonatal diabetes mellitus

doi:10.4239/wjd.v5.i2.198

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 5, Issue 2

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5795)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-6) series.

Item

Count

PDF

469

WORD

236

HTML

3290

Figures (1-6)

519

Sum=4514

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

589

Download

684

Sum=1273

Apr 15, 2014 (publication date) through Dec 2, 2024

Times Cited of This Article

Times Cited (9)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Diabetes. Apr 15, 2014; 5(2): 198-208
Published online Apr 15, 2014. doi: 10.4239/wjd.v5.i2.198

Glycemic control indicators in patients with neonatal diabetes mellitus

Shigeru Suzuki, Masafumi Koga

Shigeru Suzuki, Department of Pediatrics, Asahikawa Medical University, Asahikawa 078-8510, Hokkaido, Japan

Masafumi Koga, Department of Internal Medicine, Kawanishi City Hospital, Kawanishi, Hyogo 664-8533, Japan

Author contributions: Suzuki S wrote the first draft of the manuscript; Koga M edited and supervised the manuscripts.

Correspondence to: Masafumi Koga, MD, PhD, Department of Internal Medicine, Kawanishi City Hospital, Kawanishi, Hyogo 664-8533, Japan. m-koga@kawanishi-city-hospital.com

Telephone: +81-72-7942321 Fax: +81-72-7946321

Received: November 26, 2013
Revised: January 24, 2014
Accepted: March 13, 2014
Published online: April 15, 2014
Processing time: 142 Days and 20.5 Hours

Abstract

Neonatal diabetes mellitus (NDM) is a type of diabetes mellitus caused by genetic abnormality which develops in insulin dependent state within 6 mo after birth. HbA1c is widely used in clinical practice for diabetes mellitus as the gold standard glycemic control indicator; however, fetal hemoglobin (HbF) is the main hemoglobin in neonates and so HbA1c cannot be used as a glycemic control indicator in NDM. Glycated albumin (GA), another glycemic control indicator, is not affected by HbF. We reported that GA can be used as a glycemic control indicator in NDM. However, it was later found that because of increased metabolism of albumin, GA shows an apparently lower level in relation to plasma glucose in NDM; measures to solve this problem were needed. In this review, we outlined the most recent findings concerning glycemic control indicators in neonates or NDM.

Keywords: Glycemic control; HbA1c; Glycated albumin; Fructosamine; 1,5-anhydroglucitol; Neonatal diabetes mellitus

Core tip: Neonatal diabetes mellitus (NDM) is a type of diabetes mellitus caused by genetic abnormality which develops in insulin dependent state within 6 mo after birth. Because fetal hemoglobin (HbF) is the main hemoglobin in neonates, HbA1c cannot be used as a glycemic control indicator in NDM. On the other hand, glycated albumin (GA), another glycemic control indicator, is not affected by HbF. We reported that GA can be used as a glycemic control indicator in NDM. In this review, we outlined the most recent findings concerning glycemic control indicators in neonates or NDM.